Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Confirmatory Study For Intracordal Administration Of KP-100LI In Patients With Vocal Fold Scar

NCT05627648 is registered in ClinicalTrials.gov with Kringle Pharma, Inc. as lead sponsor.

NCT NCT05627648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05627648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Confirmatory Study For Intracordal Administration Of KP-100LI In Patients With Vocal Fold Scar
Lead sponsor
Kringle Pharma, Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 1, 2022
Completion date
February 28, 2027
Enrollment
62 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

vocal fold scar